Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Peptide & Protein Research   Volumes    Volume 1  Issue 1
Synthetic peptides for the development of a hepatitis a vaccine: Use of liposomes as adjuvants
Isabel Haro, Albert Bosch, Francisca Reig
Pages: 135 - 149
Number of pages: 15
Current Topics in Peptide & Protein Research
Volume 1  Issue 1

Copyright © 1994 Research Trends. All rights reserved

Peptides corresponding to proteins VP1, VP2 and VP3 of the capsid of the hepatitis A virion have been synthesized by the Fmoc-polyamide solid phase method, and administered to laboratory animals in three different forms: Free, encapsulated in multilamelar liposomes and coupled to keyhole limpet hemocyanin (KLH) by using glutaraldehyde as a coupling agent. Potential epitopes of HAV were selected by determining the exposed regions on the surface of the virion according to hydrophilicity profiles, calculated by the Hoop and Woods method, and protein iodination. Overall, VP3 peptide appeared to be more immunogenic than VP1 and VP2. The maximum anti-HAV titers were also observed in mice immunized with VP1 and, particularly, VP3 peptides. Neutralization of HAV infectivity was achieved with both of these peptides. Immune responses generated by peptides entrapped into liposomes and coupled to KLH were of higher magnitude than those induced by free peptides. Liposomes, are a safe and promising alternative for the enhancement of the immune response evoked by synthetic peptides.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms